Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study

Overview of attention for article published in BMC Cancer, January 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 43 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 6,463 followers.

3. Give pertuzumab plus trastuzumab for (neo) adjuvant therapy, locally recurrent or metastatic disease without chemotherapy to reduce neutropenia risk “Something better than nothing” is the mantra here https://t.co/5iiXfSRT7H 4/6

14 Apr 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.